Fenwick has advised Scribe Therapeutics. Latham & Watkins has advised the underwriters. Scribe Therapeutics Inc., a clinical-stage biotechnology company specializing in in vivo CRISPR technologies, has...
Scribe Therapeutics Completes $155.51 Million Initial Public Offering and Private Placement
Vir Biotechnology Completes $172.5 Million Public Offering of Common Stock
Gunderson Dettmer, with support from Ropes & Gray LLP, Sheppard, Mullin, Richter & Hampton LLP, and Fox Rothschild LLP, has advised Vir Biotechnology. Latham & Watkins...
Casago’s $128.6 Million Merger with Vacasa
Latham & Watkins and Vinson & Elkins advised Vacasa, Inc. on the transaction, while Fenwick & West represented Roofstock. Vacasa, Inc. (Nasdaq: VCSA), a leading vacation...
Casago’s Merger With Vacasa
Latham & Watkins is representing Vacasa, while Skadden is advising Casago on the deal. Vinson & Elkins is acting as legal advisor to the Special Committee...
Owlet’s $11.6 Million Common Stock Offering
Latham & Watkins advised Owlet in the offering, and DLA Piper advised Titan Partners Group, as underwriter. Owlet, Inc. (NYSE:OWLT), the pioneer of smart infant monitoring,...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Amphenol Corp.’s $2.025 Billion Acquisition of Carlisle Interconnect Technologies
Kirkland & Ellis is advising Carlisle Companies Incorporated on the transaction, and Latham & Walkins is advising Amphenol Corporation. Amphenol Corporation (NYSE: APH), a leading global...
Owlet’s $30 Million Private Placement Financing
Latham & Watkins represented Owlet in the financing round. Owlet, Inc. (NYSE: OWLT) announced it has consummated a sale of its newly issued Series A convertible...
Geron Corporation’s $198 Million Upsized Public Offering
Cooley advised Geron, while Latham & Watkins represented the underwriters in the offering. Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, has announced the pricing...
Infrared Cameras Holdings’ Merger With SportsMap Tech Acquisition Corp.
Latham & Watkins advised Infrared Cameras, while ArentFox Schiff advised SportsMap on the deal. Infrared Cameras Holdings, Inc., a leading provider of intelligent thermal imaging platforms,...
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
LG Chem’s Acquisition of AVEO Oncology
Latham & Watkins LLP represented LG Chem in the transaction, while WilmerHale LLP represented AVEO. LG Chem, Ltd. (KOSPI: 051910) entered into a definitive agreement to acquire...